Cefiderocol Versus Colistin for the Treatment of Carbapenem-Resistant Acinetobacter baumannii Complex Bloodstream Infections: A Retrospective, Propensity-Score Adjusted, Monocentric Cohort Study.

Davide Fiore BavaroRoberta PapagniAlessandra BelatiLucia DiellaAntonio De LucaGaetano BrindicciNicolò De GennaroFrancesco Di GennaroFederica RomanelliStefania StolfaLuigi RongaAdriana MoscaFrancesco PomaricoMaria Dell'AeraMonica StufanoLidia DalfinoSalvatore GrassoAnnalisa Saracino

Published in: Infectious diseases and therapy (2023)

Cefiderocol may be a valuable treatment option for CRAB-BSI, especially in the current context of limited treatment options.

Keyphrases

acinetobacter baumannii
multidrug resistant
drug resistant
gram negative
pseudomonas aeruginosa
escherichia coli
cystic fibrosis
combination therapy
klebsiella pneumoniae
smoking cessation